Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India
Name:
1110_Sinha_Liposomal-amphoteri ...
Size:
165.4Kb
Format:
PDF
Description:
Main article
Authors
Sinha, Prabhat Kvan Griensven, Johan
Pandey, Krishna
Kumar, Nawin
Verma, Neena
Mahajan, Raman
Kumar, Pankaj
Kumar, Ranjeet
Das, Pradeeb
Mitra, Gaurab
Flevaud, Laurence
Ferreyra, Cecilia
Remartinez, Daniel
Pece, Manuel
Palma, Pedro Pablo
Affiliation
Rajendra Memorial Research Institute of Medical Science, Patna, Bihar; Medecins Sans Frontieres–India, Operational Center Barcelona–Athens, New Delhi, India; Institute of Tropical Medicine, Antwerp, Belgium; Medecins Sans Frontieres, Medical Department, Operational Center Barcelona– Athens, Barcelona, SpainIssue Date
2011-10
Metadata
Show full item recordJournal
Clinical Infectious Diseases : an official publication of the Infectious Diseases Society of AmericaAbstract
Reports on treatment outcomes of visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection in India are lacking. To our knowledge, none have studied the efficacy of liposomal amphotericin B in VL-HIV coinfection. We report the 2-year treatment outcomes of VL-HIV-coinfected patients treated with liposomal amphotericin B followed by combination antiretroviral treatment (cART) in Bihar, India.Publisher
Oxford University PressPubMed ID
21890763Additional Links
http://cid.oxfordjournals.org/content/53/7/e91.abstractType
ArticleLanguage
enISSN
1537-6591ae974a485f413a2113503eed53cd6c53
10.1093/cid/cir521
Scopus Count
Collections
Related articles
- Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.
- Authors: Mahajan R, Das P, Isaakidis P, Sunyoto T, Sagili KD, Lima MA, Mitra G, Kumar D, Pandey K, Van Geertruyden JP, Boelaert M, Burza S
- Issue date: 2015 Oct 15
- Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
- Authors: Lachaud L, Bourgeois N, Plourde M, Leprohon P, Bastien P, Ouellette M
- Issue date: 2009 Jan 15
- Five-year field results and long-term effectiveness of 20 mg/kg liposomal amphotericin B (Ambisome) for visceral leishmaniasis in Bihar, India.
- Authors: Burza S, Sinha PK, Mahajan R, Lima MA, Mitra G, Verma N, Balasegaram M, Das P
- Issue date: 2014
- Limited effectiveness of high-dose liposomal amphotericin B (AmBisome) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence.
- Authors: Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, Davidson RN
- Issue date: 2011 Dec
- Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
- Authors: Salih NA, van Griensven J, Chappuis F, Antierens A, Mumina A, Hammam O, Boulle P, Alirol E, Alnour M, Elhag MS, Manzi M, Kizito W, Zachariah R
- Issue date: 2014 Feb